The Vanguard Group 13D and 13G filings for Edwards Lifesciences Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-30 9:34 pm Purchase |
2024-12-31 | 13G | Edwards Lifesciences Corporation EW |
The Vanguard Group | 69,131,602 11.720% |
6,537,494 (+10.44%) |
Filing |
| 2024-10-04 2:14 pm Purchase |
2024-09-30 | 13G | Edwards Lifesciences Corporation EW |
The Vanguard Group | 62,594,108 10.390% |
10,231,195 (+19.54%) |
Filing |
| 2024-02-13 5:04 pm Purchase |
2023-12-29 | 13G | Edwards Lifesciences Corporation EW |
The Vanguard Group | 52,362,913 8.630% |
803,522 (+1.56%) |
Filing |
| 2023-02-09 11:16 am Purchase |
2022-12-30 | 13G | Edwards Lifesciences Corporation EW |
The Vanguard Group | 51,559,391 8.340% |
2,482,742 (+5.06%) |
Filing |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Edwards Lifesciences Corporation EW |
The Vanguard Group | 49,076,649 7.860% |
728,964 (+1.51%) |
Filing |
| 2021-02-10 10:52 am Sale |
2020-12-31 | 13G | Edwards Lifesciences Corporation EW |
The Vanguard Group | 48,347,685 7.760% |
-437,421 (-0.90%) |
Filing |